Report and Slides from the Management of Depression: Guidelines and Beyond Meeting - 17th September 2018

The PAX-BD Launch meeting at the Hallam Conference Centre, London W1 presented lectures from psychiatrists prominent in the field of Bipolar Disorder and depression. It was attended by 49 clinical and academic Psychiatrists each with an interest in the future of Treatment Resistant Bipolar Depression (TRBD). Many patients suffer from TRBD; with around half of patients remaining depressed at six months and a third at a year, this is an area that requires urgent attention. 

Links to slides's from the meeting:

Andrea Cipriani'Evidence based treatment for unipolar depression'

John Geddes: 'The Next Generation of UK Trials: PAX-BD - Pro-dopaminergic therapy in treatment resistant depression'

Hamish McAllister-Williams:'Bipolar depression guidelines and the PAX-BD study'

The PAX-BD Study Team: 'Randomised placebo-controlled train of pramipexole addition to mood stabilisers for treatment-resistant bipolar depression (PAX-BD)'

James Rucker: 'Back to the Future: Psilocybin Trials in Treatment Resistant Depression in the UK'

Ed Bullmore: 'Treating the Inflamed Mind'

Hamish McAllister-Williams: 'VNS and Restore Life'